Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Marthas

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Virology|October 1, 1993
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmacM L Marthas, R A Ramos, B L Lohman, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, J M Cherrington, M L Marthas, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaquesK K Van Rompay, M L Marthas, J D Lifson, et al.
AIDS Research and Human Retroviruses|March 1, 1992
Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac)P A Luciw, K E Shaw, R E Unger, et al.
Journal of Virology|November 1, 1994
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challengeB L Lohman, M B McChesney, C J Miller, et al.
AIDS Research and Human Retroviruses|November 1, 1991
Functional and immunological characterization of SIV envelope glycoprotein produced in genetically engineered mammalian cellsV Planelles, N L Haigwood, M L Marthas, et al.
Journal of Virology|March 12, 1999
Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaquesK K van Rompay, P J Dailey, R P Tarara, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaquesK K Van Rompay, J M Cherrington, M L Marthas, et al.
Journal of Virology|January 22, 2000
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, M D Miller, M L Marthas, et al.
The Journal of Infectious Diseases|May 21, 1998
Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infectionK K Van Rompay, C J Berardi, S Dillard-Telm, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Virology|October 1, 1993
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmacM L Marthas, R A Ramos, B L Lohman, et al.
Antimicrobial Agents and Chemotherapy|April 2, 1999
9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, J M Cherrington, M L Marthas, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaquesK K Van Rompay, M L Marthas, J D Lifson, et al.
AIDS Research and Human Retroviruses|March 1, 1992
Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac)P A Luciw, K E Shaw, R E Unger, et al.
Journal of Virology|November 1, 1994
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challengeB L Lohman, M B McChesney, C J Miller, et al.
AIDS Research and Human Retroviruses|November 1, 1991
Functional and immunological characterization of SIV envelope glycoprotein produced in genetically engineered mammalian cellsV Planelles, N L Haigwood, M L Marthas, et al.
Journal of Virology|March 12, 1999
Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaquesK K van Rompay, P J Dailey, R P Tarara, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaquesK K Van Rompay, J M Cherrington, M L Marthas, et al.
Journal of Virology|January 22, 2000
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, M D Miller, M L Marthas, et al.
The Journal of Infectious Diseases|May 21, 1998
Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infectionK K Van Rompay, C J Berardi, S Dillard-Telm, et al.
Pageof 4